Drolet B, Khalifa M, Daleau P, Hamelin B A, Turgeon J
Quebec Heart Institute, Laval Hospital, Faculty of Pharmacy, Laval University, Ste-Foy, Canada.
Circulation. 1998 Jan 20;97(2):204-10. doi: 10.1161/01.cir.97.2.204.
Lengthening of the QT interval and torsades de pointes resulting in cardiac arrests and deaths have been noticed during treatment with cisapride, a newly developed gastrointestinal prokinetic agent. The rapid (I[Kr]) and slow (I[Ks]) components of the delayed rectifier current (I[K]) are candidate ionic currents to explain cisapride-related toxicity because of their role in repolarization of cardiac ventricular myocytes. Our objectives were to (1) characterize effects of cisapride on two major time-dependent outward potassium currents involved in the repolarization of cardiac ventricular myocytes, I(Kr) and I(Ks), and (2) determine action potential-prolonging effects of cisapride on isolated hearts.
A first set of experiments was performed in isolated guinea pig ventricular myocytes with the whole-cell configuration of the patch-clamp technique. Cells were held at -40 mV while time-dependent outward currents were elicited by depolarizing pulses lasting either 250 ms (I[K250]) or 5000 ms (I[K5000]). Effects of cisapride on the I(Kr) component were assessed by measurement of time-dependent activating currents elicited by short pulses (250 ms; I[K250]) to low depolarizing potentials (-20, -10, and 0 mV). Time-dependent activating currents elicited by long pulses (5000 ms; I[K5000]) to positive potentials (>+30 mV) were recorded to assess effects of the drug on the I(Ks) component. A second set of experiments was conducted in isolated guinea pig hearts buffer-perfused in the Langendorff mode to assess effects of the drug on monophasic action potential duration measured at 90% repolarization (MAPD90). Hearts were exposed to cisapride 100 nmol/L at decremental pacing cycle lengths of 250, 225, 200, 175, and 150 ms to determine reverse frequency-dependent effects of the drug. Overall, 112 myocytes were exposed to seven concentrations of cisapride (10 nmol/L to 10 micromol/L). Cisapride inhibited I(Kr), the major time-dependent outward current elicited by short pulses (I[K250]) to low depolarizing potentials, in a concentration-dependent manner with an IC50 of 15 nmol/L (therapeutic levels, 50 to 200 nmol/L). Conversely, block of I(Ks) by the drug was less potent (estimated IC50 >10 micromol/L). In isolated hearts (n=9 experiments), cisapride 100 nmol/L increased MAPD90 by 23+/-3 (P<.05) at a basic cycle length of 250 ms but by only 7+/-1 ms (P<.05) at a basic cycle length of 150 ms.
Block of I(Kr) gives an explanation to lengthening of cardiac repolarization observed in isolated guinea pig hearts. Potent block of I(Kr) is also likely to underlie prolongation of the QT interval observed in patients receiving clinically recommended doses of cisapride as well as severe cardiac toxicity (torsades de pointes) observed in patients with increased plasma concentrations of the drug.
西沙必利是一种新开发的胃肠促动力药,在其治疗过程中已注意到QT间期延长和尖端扭转型室速导致心脏骤停和死亡。延迟整流钾电流(I[K])的快速成分(I[Kr])和慢速成分(I[Ks])是解释西沙必利相关毒性的候选离子电流,因为它们在心室肌细胞复极化中起作用。我们的目的是:(1) 描述西沙必利对参与心室肌细胞复极化的两种主要时间依赖性外向钾电流I(Kr)和I(Ks)的影响;(2) 确定西沙必利对离体心脏动作电位延长的影响。
第一组实验采用膜片钳技术的全细胞模式,在分离的豚鼠心室肌细胞中进行。细胞钳制在-40mV,通过持续250ms(I[K250])或5000ms(I[K5000])的去极化脉冲诱发时间依赖性外向电流。通过测量短脉冲(250ms;I[K250])至低去极化电位(-20、-10和0mV)诱发的时间依赖性激活电流,评估西沙必利对I(Kr)成分 的影响。记录长脉冲(5000ms;I[K5000])至正电位(>+30mV)诱发的时间依赖性激活电流,以评估药物对I(Ks)成分的影响。第二组实验在Langendorff模式下缓冲灌注的离体豚鼠心脏中进行,以评估药物对90%复极化时单相动作电位时程(MAPD90)的影响。心脏在递减的起搏周期长度250、225、200、175和150ms下暴露于浓度为100nmol/L的西沙必利,以确定药物的反向频率依赖性效应。总体而言,112个心肌细胞暴露于七种浓度的西沙必利(从10nmol/L至10μmol/L)。西沙必利以浓度依赖性方式抑制短脉冲(I[K250])至低去极化电位诱发的主要时间依赖性外向电流I(Kr),IC50为15nmol/L(治疗水平为50至200nmol/L)。相反,该药对I(Ks)的阻断作用较弱(估计IC50>10μmol/L)。在离体心脏(n = 9次实验)中,浓度为100nmol/L的西沙必利在基础周期长度为250ms时使MAPD90增加23±3(P <.05),但在基础周期长度为150ms时仅增加7±1ms(P <.05)。
I(Kr)的阻断解释了在离体豚鼠心脏中观察到的心脏复极化延长。强效阻断I(Kr)也可能是接受临床推荐剂量西沙必利的患者QT间期延长以及血浆药物浓度升高的患者出现严重心脏毒性(尖端扭转型室速)的原因。